日月明 (300906.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 2.48B

MomentumView details →

1D Return

+1.31%

YTD Return

−15.37%

RSI (14)

53.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 2.48B

RSI (14)

53.5

MomentumView details →

1D Return

+1.31%

YTD Return

−15.37%

ProfitabilityView details →

Gross Margin

52.12%

Net Margin

33.95%

EBITDA Margin

39.80%

ROE (TTM)

6.28%

ROA (TTM)

5.56%

Asset Turnover

0.16x

GrowthView details →

Revenue YoY

+8.68%

EPS YoY

−21.36%

FCF YoY

−87.47%

Revenue CAGR 3Y

+14.40%

EPS CAGR 3Y

+23.28%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

8.29x

Quick Ratio

8.15x

Div Yield

0.50%

Div Rate

CNY 0.15

Div Growth 1Y

−70.00%

Financials snapshotView financials →

Revenue (TTM)

173.28M

Net Income (TTM)

58.83M

Op. CF (TTM)

13.96M

Latest newsMore news →

Riyueming announced its H1 2026 results: net profit attributable to shareholders was 19.6828 million yuan, down 9.96% year-on-year.9d ago

Riyueming repurchased 34,200 of its own shares on 2026-07-30 through centralized bidding trading, representing 0.04% of total share capital, for a total transaction amount of 841,100 yuan.35d ago

Similar companies

英力特000635.SZ 腾亚精工301125.SZ 美信科技301577.SZ 好利科技002729.SZ 金浦钛业000545.SZ 泰林生物300813.SZ Find similar companies →

Latest newsMore news →

Riyueming announced its H1 2026 results: net profit attributable to shareholders was 19.6828 million yuan, down 9.96% year-on-year.9d ago Riyueming repurchased 34,200 of its own shares on 2026-07-30 through centralized bidding trading, representing 0.04% of total share capital, for a total transaction amount of 841,100 yuan.35d ago